Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cathy Maes
Institutions:
Ghent University Hospital,
Ghent University
Observed institutions:
Ghent University Hospital,
Ghent University
ORCID:
0000-0001-5932-2272
Observed ORCID:
0000-0001-5932-2272
OpenAlex ID:
A5057853284
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial
2021
·
Peter G. Kremsner
, Philipp Mann
, et al.
·
Wiener klinische Wochenschrift
·
212
PDF
Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
2009
·
Isabel Leroux-Roels
, François Roman
, et al.
·
Vaccine
·
148
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
2013
·
Geert Leroux-Roels
, Cathy Maes
, et al.
·
PLoS ONE
·
91
PDF
A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women
2016
·
Geert Leroux-Roels
, Cathy Maes
, et al.
·
Vaccine
·
78
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study
2014
·
Geert Leroux-Roels
, Cathy Maes
, et al.
·
Vaccine
·
74
PDF
Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials
2011
·
François Roman
, Frédéric Clément
, et al.
·
Clinical and Vaccine Immunology
·
54
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial
2017
·
Opokua Ofori-Anyinam
, Geert Leroux-Roels
, et al.
·
Vaccine
·
38
PDF
Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial
2019
·
Geert Leroux-Roels
, Zourab Bebia
, et al.
·
Clinical Infectious Diseases
·
37
PDF
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study
2024
·
Isabel Leroux-Roels
, Cathy Maes
, et al.
·
The Journal of Infectious Diseases
·
35
Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study
2019
·
Geert Leroux-Roels
, Fien De Boever
, et al.
·
Vaccine
·
34
PDF
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
2022
·
Isabel Leroux-Roels
, Cathy Maes
, et al.
·
Frontiers in Immunology
·
30
PDF
Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine
2011
·
Geert Leroux-Roels
, Edwige Haelterman
, et al.
·
Clinical and Vaccine Immunology
·
26
Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine
2023
·
Isabel Leroux-Roels
, Jacques Bruhwyler
, et al.
·
Vaccines
·
20
PDF
Pregnancy has a minimal impact on the acute transcriptional signature to vaccination
2020
·
John S. Tregoning
, January Weiner
, et al.
·
npj Vaccines
·
13
PDF
Immune Reactivity of Mycobacterium Bovis (strain Bcg) and Mycobacterium Vaccae
2004
·
M Rennou
, Cathy Maes
, et al.
·
1
1110Identification of Formulations and Vaccine Schedules of a Trivalent Group B Streptococcus Vaccine for Further Development in Non-pregnant and Pregnant Women
2014
·
Geert Leroux-Roels
, Cathy Maes
, et al.
·
Open Forum Infectious Diseases
Heterologous prime-boost H5N1 vaccination strategy results in rapid anamnestic responses against both strains after booster vaccination
2009
·
Karine Levie
, Isabel Leroux–Roels
, et al.
Show more works
View as search
Works count:
17
Citation count:
891
H-index:
13
I10-index:
14
Year
Topic
Type